1. Home
  2. RLMD vs ROMA Comparison

RLMD vs ROMA Comparison

Compare RLMD & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • ROMA
  • Stock Information
  • Founded
  • RLMD 2004
  • ROMA 2018
  • Country
  • RLMD United States
  • ROMA Hong Kong
  • Employees
  • RLMD N/A
  • ROMA N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • ROMA Savings Institutions
  • Sector
  • RLMD Health Care
  • ROMA Finance
  • Exchange
  • RLMD Nasdaq
  • ROMA Nasdaq
  • Market Cap
  • RLMD 11.5M
  • ROMA 10.5M
  • IPO Year
  • RLMD N/A
  • ROMA 2024
  • Fundamental
  • Price
  • RLMD $0.30
  • ROMA $0.73
  • Analyst Decision
  • RLMD Hold
  • ROMA
  • Analyst Count
  • RLMD 4
  • ROMA 0
  • Target Price
  • RLMD $4.25
  • ROMA N/A
  • AVG Volume (30 Days)
  • RLMD 2.1M
  • ROMA 42.4K
  • Earning Date
  • RLMD 03-18-2025
  • ROMA 12-16-2024
  • Dividend Yield
  • RLMD N/A
  • ROMA N/A
  • EPS Growth
  • RLMD N/A
  • ROMA N/A
  • EPS
  • RLMD N/A
  • ROMA N/A
  • Revenue
  • RLMD N/A
  • ROMA $1,029,120.00
  • Revenue This Year
  • RLMD N/A
  • ROMA N/A
  • Revenue Next Year
  • RLMD N/A
  • ROMA N/A
  • P/E Ratio
  • RLMD N/A
  • ROMA N/A
  • Revenue Growth
  • RLMD N/A
  • ROMA N/A
  • 52 Week Low
  • RLMD $0.28
  • ROMA $0.40
  • 52 Week High
  • RLMD $7.22
  • ROMA $1.85
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 30.81
  • ROMA 55.32
  • Support Level
  • RLMD $0.28
  • ROMA $0.58
  • Resistance Level
  • RLMD $0.36
  • ROMA $0.71
  • Average True Range (ATR)
  • RLMD 0.04
  • ROMA 0.07
  • MACD
  • RLMD 0.02
  • ROMA 0.01
  • Stochastic Oscillator
  • RLMD 7.21
  • ROMA 88.24

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

Share on Social Networks: